Functional Neurological Disorder and Dissociation: Overlap and Differences
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Functional neurological disorder (FND) and dissociation overlap in clinical experience, research findings, and the history of psychiatric classification. Some people with FND experience depersonalization, derealization, disruptions in awareness, memory gaps, or an altered sense of bodily control. Some dissociative experiences occur during functional seizures. However, the two terms describe different levels of clinical information: FND refers to particular neurological symptoms supported by a neurological assessment, whereas dissociation describes disruptions in the integration of awareness, memory, identity, perception, and bodily experience and can also occur in several separately diagnosed disorders.
The central clinical conclusion is that dissociation deserves careful assessment in people with FND, while neither diagnosis follows automatically from the other. In a systematic review and meta-analysis of 75 studies, dissociative symptoms were elevated in FND samples compared with several control groups. The authors emphasized heterogeneity, risk of bias, and uncertainty about mechanisms. The association supports a clinically meaningful overlap, not a universal cause or a single combined diagnosis.
This article explains what overlaps, how DSM-5-TR and ICD-11 classify the conditions differently, what the research actually shows, how clinicians investigate overlapping symptoms, and how treatment planning changes when both functional neurological and dissociative experiences are present. It is an informational clinical reference rather than an individual diagnostic assessment.
The Short Answer: How Are FND and Dissociation Related?
FND is a disorder of neurological functioning involving symptoms such as functional weakness, tremor, gait disturbance, sensory disturbance, speech difficulties, or functional seizures. Diagnosis depends on a characteristic clinical presentation and positive neurological evidence, interpreted alongside appropriate investigation and differential diagnosis. Clinicians look for internally inconsistent or incongruent neurological findings in the relevant context, rather than inferring FND from normal scans alone. See the clinical review by Aybek and Perez.
Dissociation is a clinical and psychological construct describing discontinuities or disruptions in the integration of mental or bodily experience. It can include detachment from oneself (depersonalization), the experience that the world is unreal (derealization), significant gaps in autobiographical memory, changes in awareness, or disturbances in felt agency. A dissociative symptom is not by itself a dissociative disorder. Clinical diagnosis depends on its form, severity, persistence, impairment, and competing explanations.
The overlap is particularly visible in seizure-like episodes, altered awareness, detachment, and some experiences of bodily agency. Nevertheless, a person with functional limb weakness can have no clinically significant dissociation, while a person with depersonalization/derealization disorder can have no functional neurological deficit. The research question is how and when these experiences coexist and interact, not whether the names are interchangeable.
What Is Functional Neurological Disorder?
FND refers to neurological symptoms that clinicians identify through a recognizable functional clinical pattern. Motor presentations can include weakness, tremor, dystonia-like posturing, gait disturbance, or unusual movements. Sensory, speech, and seizure presentations also occur. The symptoms can be profoundly disabling, fluctuate, and coexist with other physical illnesses. A diagnosis has to account for the observed neurological findings; it does not require an assumption that a patient consciously creates symptoms or that psychological stress must have caused them.
For example, a neurologist may observe a positive sign of functional limb weakness such as Hoover's sign when correctly elicited and interpreted. In movement presentations, changes associated with distraction or entrainment can be clinically informative. These findings have particular contexts and limitations. No single demonstration by a nonclinician establishes FND, and the examination must still consider structural, inflammatory, vascular, epileptic, metabolic, and other neurological conditions. Dworetzky and Baslet's practical review describes the importance of positive diagnosis and avoiding common diagnostic pitfalls.
The term functional describes a disorder in how neurological functions are produced or regulated in the clinical presentation. It is not a statement about dishonesty, intelligence, personality, or whether suffering is genuine. Many patients require coordinated neurology, rehabilitation, and psychological care, with the mix of interventions determined by subtype and individual needs. The broader condition is explained in Functional Neurological Disorder: Symptoms, Diagnosis, and Treatment.
What Does Dissociation Mean?
Dissociation concerns alterations in the usual integration of consciousness, memory, identity, emotion, perception, body representation, motor control, or behavior. It describes a domain of experience and can occur across diagnoses and in circumstances that do not satisfy any disorder's criteria. The American Psychiatric Association's DSM-5-TR distinguishes specific dissociative disorders, while the World Health Organization's ICD-11 clinical requirements use their own diagnostic organization.
Psychoform dissociation commonly refers in research to disruptions in psychological functions such as awareness, memory, identity, and perception. Somatoform dissociation is a research term for dissociative-like alterations expressed through bodily functions or sensations. These research measures are not equivalent to diagnostic criteria, and some questionnaires incorporate neurological-like complaints that can overlap directly with FND symptoms. This measurement overlap makes causal conclusions particularly difficult.
Depersonalization is often described as feeling detached from one's body, thoughts, emotions, or actions. Derealization involves a feeling of unreality or distance from the environment. Dissociative amnesia describes significant autobiographical memory gaps that require assessment beyond ordinary forgetting. Identity-related dissociative disorders have specific additional diagnostic requirements. For the general symptom domain, see Dissociation: Symptoms, Types, Causes, and When to Seek Help.
FND vs Dissociation: The Main Clinical Differences
The principal distinction is what clinicians are trying to establish. When evaluating possible FND, the central question is whether a particular neurological symptom pattern is supported by positive examination features and the appropriate differential assessment. When evaluating dissociative experiences, the clinician asks what changes in awareness, memory, identity, self-experience, or perception occur, how they are linked to circumstances, and whether a defined dissociative disorder's criteria are satisfied.
An observable functional tremor and a subjective feeling of being detached from one's hands may both occur during the same episode, but they represent different observations. The tremor requires a movement-disorder assessment. The felt detachment requires a careful phenomenological interview. The patient may have one, both, or another explanation entirely. Neither observation removes the need to address the other.
A second difference concerns diagnostic specificity. FND is a recognizable clinical syndrome with neurological subtypes. Dissociation is also a broader dimension of experience, so it should not be used as a loose replacement diagnosis for any event involving altered awareness or a sense of unfamiliarity. In clinical records, the phrase dissociative disorder should identify a specific, assessed diagnostic category whenever possible.
A third difference is the risk of circular reasoning. If a person has a functional attack and describes feeling unreal before it, that description may be clinically valuable. It does not prove that derealization caused the attack. Similarly, recognizing a functional symptom does not demonstrate the presence of hidden trauma, dissociative identity disorder, or a particular psychological conflict.
Why DSM-5-TR and ICD-11 Classify the Conditions Differently
The DSM-5-TR places functional neurological symptom disorder (conversion disorder) in the chapter Somatic Symptom and Related Disorders. Its diagnostic model emphasizes motor or sensory neurological symptoms together with clinical findings showing incompatibility with recognized neurological or medical conditions, in context. The manual treats dissociative identity disorder, dissociative amnesia, depersonalization/derealization disorder, and related diagnoses in a separate Dissociative Disorders chapter. The frameworks are distinct even though a patient can experience symptoms from both domains.
ICD-11 places dissociative neurological symptom disorder, code 6B60, in its Dissociative Disorders grouping. Subcategories identify clinical presentations such as non-epileptic seizures, weakness, gait disturbance, movement symptoms, sensory disturbance, speech disturbance, and cognitive symptoms. ICD-11 also classifies other dissociative conditions separately within that grouping. These are formal organizational choices documented in the 2024 WHO Clinical Descriptions and Diagnostic Requirements.
This distinction explains an apparent contradiction in English-language sources. Some texts call functional seizures dissociative seizures, while others refer to them as psychogenic nonepileptic seizures (PNES) or functional seizures. The names reflect historical conventions and classification systems; the neurological assessment remains essential. It is inaccurate to conclude solely from ICD-11 chapter placement that every person with functional seizures has dissociative amnesia, depersonalization, or a separate dissociative disorder.
The broader terms FND and dissociation therefore require the manual, the diagnostic level, and the clinical symptom type to be specified when a cross-system comparison is made. A direct label-to-label translation can obscure relevant differences in criteria and clinical practice. Aybek and Perez and the WHO CDDR provide complementary accounts.
What the Research Shows About Overlap
The most directly relevant synthesis is Campbell and colleagues' systematic review and meta-analysis of dissociation in FND. It included 75 studies, with 3,940 participants with FND and 3,073 controls. Relative to healthy controls, psychoform dissociation showed a large pooled standardized difference (Hedges g = 0.90); relative to neurological controls, the pooled difference was smaller (g = 0.56). Somatoform dissociation was also elevated compared with healthy controls (g = 1.80). These are study-level group comparisons, not probabilities that any given individual will have a dissociative disorder.
The included populations and measures were heterogeneous, with substantial differences in study design, comparator selection, and symptom subtype. Functional-seizure samples were particularly prominent, while functional motor cohorts were less extensively studied. When studies enroll predominantly people attending specialty services, prevalence and severity may differ from those in general neurology or primary care. The review also described associations between dissociation and more severe FND symptoms or poorer quality of life, but cross-sectional observations cannot establish the direction of influence.
An especially important interpretive limitation concerns scales that define somatoform dissociation using bodily sensations or functional-like complaints. Such a measure can rise partly because it counts symptoms already central to FND. That is a meaningful description of co-occurring experiences but is insufficient to infer a single underlying mechanism. Measurement methods need to separate symptom severity, bodily awareness, dissociative detachment, and diagnostic criteria.
A second limitation is that dissociation is not distributed uniformly across FND subtypes. Functional seizure research may find more prominent alterations in awareness or memory than studies of isolated weakness or tremor. Even within one subtype, some patients report frequent depersonalization or derealization, while others report none. That heterogeneity argues for assessment driven by the patient's actual experience.
Functional Seizures and Dissociation
Functional seizures are episodes that resemble epileptic seizures in some features but belong to the functional neurological clinical domain. They may involve shaking, unresponsiveness, apparent loss of control, behavioral arrest, or changes in awareness. Some people report detachment, derealization, or patchy memory before, during, or after a functional event. Other individuals report no subjective dissociation. The existence of an altered-awareness episode does not independently prove functional seizures.
A functional seizure and an epileptic seizure can resemble one another clinically. They can also coexist in the same patient. Diagnosis draws on detailed event descriptions, witness accounts, characteristic positive semiological features, neurological evaluation, and video-EEG when appropriate and feasible. A normal routine EEG by itself does not establish a functional diagnosis; the timing and type of recording matter. The 2026 American Academy of Neurology practice guideline addresses accurate diagnosis and treatment and the need to assess concurrent epilepsy.
The words dissociative seizures are used in some clinical systems and research programs, including the CODES trial. They should be understood as terminology for a seizure-like functional presentation, not as a finding that the patient necessarily meets diagnostic criteria for dissociative identity disorder or dissociative amnesia. A separate dissociative diagnosis requires its own evaluation.
Treatment also depends on correct classification. Antiseizure medications may be needed for confirmed concurrent epilepsy, while medication prescribed solely for functional seizures requires review by the treating clinician. Patients should not stop prescribed medication independently. Emergency evaluation remains appropriate for a first seizure-like episode, prolonged unresponsiveness, significant injury, or other concerning changes.
A 2026 systematic review of subjective experiences in functional/dissociative seizures synthesized 47 studies and found substantial variation in sensory, emotional, arousal-related, cognitive, motor, and awareness-related reports. Changes in awareness or a mismatch between awareness and responsiveness appeared more consistently useful in comparisons with epilepsy than most other subjective symptoms, but the authors stressed the lack of specificity of individual experiences and the need for structured, context-sensitive assessment. These findings refine clinical interviewing; they do not turn any one reported sensation into a diagnostic test.
Depersonalization, Derealization, and Altered Bodily Agency
Depersonalization may involve feeling like an observer of one's own actions or sensing that a hand, face, or voice is strangely unfamiliar. Derealization may make the surrounding environment feel distant or artificial. Such experiences can occur with panic, extreme sleep deprivation, some medications or substances, neurological conditions, trauma-related states, and FND. Their presence is a reason to clarify the experience and circumstances, not a shortcut to naming a cause.
FND can itself affect the feeling of agency, particularly when movements occur outside the person's expected voluntary control. Research on predictive processing, attention, self-monitoring, and sensory-motor expectations offers possible accounts of these experiences. The models are under active study and have not yielded a single, clinically validated mechanism applicable to all FND cases. Experiences of reduced motor agency should not simply be equated with disturbances of personal identity.
A careful clinical interview distinguishes feeling disconnected from movement, experiencing involuntary movement, believing another identity controls the body, losing time, having absent responsiveness, and failing to remember the episode. Similar language can conceal different phenomena. The clinician also considers whether the experience was present before the neurological symptom, arose during it, or followed it.
Memory Gaps, Awareness Changes, and Functional Cognitive Symptoms
Patients sometimes describe lost time, fragmented recall of seizure-like episodes, difficulty concentrating, or unreliable access to recent memories. These symptoms have a broad differential diagnosis. Epilepsy, sleep disorders, syncope, head injury, metabolic disturbances, substance effects, medication adverse effects, delirium, and other neurological conditions can all affect awareness or recall. Dissociative amnesia involves a more specific clinical pattern and should not be assigned to ordinary memory lapses.
Functional cognitive symptoms may involve discrepancies between a person's subjective difficulty and performance across tasks or contexts. Current functional cognitive disorder research is developing a positive diagnostic approach, but proposed criteria and terminology require careful interpretation and neurological differential assessment. That specific clinical entity is distinct from the phenomenon of losing awareness during a seizure-like event and from identity-related dissociative diagnoses.
Assessment may include neurological examination, targeted cognitive evaluation, sleep and medication review, witness information, and appropriate investigations. Neuropsychological tests can contribute when indicated, but neither a normal score nor a single inconsistency establishes an entire syndrome. Detailed longitudinal information is often more useful than treating one symptom label as conclusive.
Trauma, Stress, and Dissociation in FND
Trauma-related experiences, stressful events, and dissociative symptoms may be relevant in some people's history and symptom formulation. They are not universal prerequisites for FND. In a systematic review and meta-analysis of case-control studies, Ludwig and colleagues found higher rates of stressful life events and maltreatment among FND groups than among controls. Importantly, studies that directly assessed absence of stressors also identified people with FND who reported none.
An association across groups cannot determine why a particular individual developed neurological symptoms. Stress exposure is common, memory and disclosure are imperfect, and research designs differ in how events are measured. Even when trauma and FND coexist, a clinician must establish what the person has experienced and how it relates to their current needs, rather than declaring a particular event the cause.
A 2025 perspective in Nature Reviews Psychology proposed that PTSD research on emotion processing, interoception, self-appraisal, dissociation, and stress responses might inform more targeted FND treatment. It is explicitly a mechanistic and treatment-development perspective, not proof that FND is PTSD or that every case is trauma-mediated. The trauma-specific diagnosis and treatment questions belong in their own clinical assessment.
When trauma symptoms are present, thoughtful trauma-informed care can improve communication, consent, safety, and treatment engagement. Trauma-focused interventions should be considered for a demonstrated trauma-related condition and tailored to stability, preferences, and response. Automatically prescribing intensive trauma processing to everyone with FND would go beyond the evidence. For a broader review of the dissociation–trauma relationship, see Dissociation and Trauma: What Research Shows.
Are FND and Dissociative Disorders Separate Diagnoses?
They can be. In DSM-5-TR, a patient may meet the criteria for functional neurological symptom disorder and independently meet criteria for a dissociative disorder. One set of symptoms should not be used to infer the second diagnosis. A clinician should record each diagnosis only when the relevant evidence and criteria support it.
For example, a person with positive examination findings for functional gait disturbance may also experience recurrent depersonalization/derealization with clinically significant impairment. Evaluation should establish whether those detachment experiences satisfy the separate disorder's criteria or are better understood as symptoms associated with panic, trauma-related states, medical issues, or other contexts. Another person may have FND without a separate dissociative diagnosis, even if they experience brief moments of detachment.
ICD-11 places dissociative neurological symptom disorder in the dissociative grouping, but the grouping name must not substitute for the diagnostic requirements of dissociative identity disorder, amnesia, or other categories. Classification is a guide to recording the clinical syndrome; it does not by itself demonstrate the neurobiological mechanism.
How Clinicians Assess FND With Possible Dissociation
Assessment begins with a precise history of the presenting neurological symptom: onset, evolution, severity, functional impact, associated physical symptoms, past medical history, medications, and what happens during typical episodes. For an episodic event, witnesses' observations, descriptions of responsiveness, movement patterns, timing, and recovery can be valuable. Neurological examination then looks for relevant positive signs. Investigations are selected according to the clinical problem, not as a ritual to prove there is no disease anywhere in the body.
The interview about dissociation asks separately about feeling detached from oneself, the reality of the environment, memory discontinuities, altered awareness, and changes in the felt ownership or control of actions. It explores duration, triggers, context, awareness during events, distress, and consequences for life. Particular care is needed when a patient uses everyday phrases such as spacing out, blacking out, switching off, or not being myself; they do not each map onto one clinical diagnosis.
Clinicians also evaluate anxiety, panic, depression, PTSD symptoms, sleep, pain, fatigue, and other medical and psychiatric conditions when relevant. Psychological and neurological assessments should inform one another. A longstanding functional diagnosis never means that new weakness, a new type of seizure, acute confusion, or changing medical signs can be ignored.
The explanation given to the patient should identify the positive findings supporting FND, distinguish these from unresolved questions, and acknowledge dissociative experiences in the person's own language. A coherent explanation can facilitate engagement with rehabilitation while preserving appropriate medical vigilance. The 2025 practical management review emphasizes multidisciplinary care and careful explanation.
Do Dissociation Questionnaires Diagnose FND?
No. Instruments measuring dissociative experiences can support a structured history and track symptom dimensions, but a score is not a diagnosis of FND or of a dissociative disorder. Some instruments were validated in particular populations, use different concepts of dissociation, and may be affected by symptoms also counted in FND. A questionnaire therefore needs interpretation alongside the actual questions, patient context, examination, and diagnostic interview.
Similarly, neurological examination findings and neuropsychological measures must be interpreted by qualified clinicians. They are evidence within an assessment, not standalone online tests. A high symptom score can indicate the need for further evaluation; a low score does not reliably exclude a relevant clinical problem.
A useful assessment may measure functional neurological symptom burden and dissociative experiences separately over time. When both are tracked, the clinician can evaluate whether detachment changes independently of mobility, seizures, mood, or stress. This helps avoid assuming that improvement in one domain guarantees improvement in another.
Differential Diagnosis: What Else Can Produce Similar Experiences?
Epileptic seizures, syncope, sleep disorders, migraine phenomena, medication effects, and metabolic or other neurological disorders can produce episodes of altered awareness, unusual movements, or incomplete recall. Clinical pattern recognition, positive signs, and appropriately selected testing distinguish these possibilities. An isolated appearance of dissociation or a normal routine EEG cannot settle the differential.
Panic attacks can include intense derealization, depersonalization, shaking, dizziness, tingling, or fear of losing control. Panic can coexist with FND, and panic-associated bodily symptoms can resemble some functional or seizure-like experiences. The sequence of autonomic arousal, subjective fear, movements, duration, and recovery can be informative, but no single sign diagnoses one condition by itself.
PTSD may include dissociative features, hyperarousal, avoidance, intrusions, and trauma-related distress. These features have their own assessment requirements. OCD can involve repetitive checking and intrusive fears, which differ from involuntary neurological deficits or dissociative memory discontinuity. Depression, attention problems, sleep loss, and substance exposure can also affect subjective memory and awareness. None of these conditions should be diagnosed solely from a word such as detached or foggy.
Dissociative identity disorder and related dissociative diagnoses have specific requirements involving identity discontinuity and other symptoms. Their diagnostic assessment cannot be replaced by a general FND screening interview. Likewise, a clinician should avoid interpreting a patient's unusual motor symptom as evidence of deliberate deception. Factitious behavior and malingering raise separate questions of intentionality that cannot be inferred from inconsistent movement or symptoms.
Treatment When Functional and Dissociative Symptoms Coexist
Treatment begins with a collaborative explanation of the established diagnosis, clear identification of any remaining diagnostic questions, and a plan for the patient's primary sources of impairment. Functional weakness or gait problems may call for FND-informed physiotherapy and occupational therapy; functional seizures may call for seizure-specific psychological treatment and coordinated neurology follow-up. Prominent dissociative distress may warrant psychotherapy addressing awareness, stabilization, emotion regulation, and the circumstances surrounding episodes.
The 2025 umbrella review of FND treatments found potentially useful effects for cognitive behavioral approaches and rehabilitation, while emphasizing variable methodology and evidence certainty. A 2026 systematic review and meta-analysis of FND rehabilitation trials reported improvements across many programs but substantial heterogeneity and limited certainty in some pooled outcomes. Those studies do not prove that any one treatment specifically reverses dissociation in all FND subtypes.
Psychotherapy may help patients recognize warning sensations, attend differently to episodes, address fear and avoidance, build routines, and manage co-occurring psychiatric problems. Techniques often described as grounding may be useful to some people during detachment, but responses vary and a technique should be modified if it worsens symptoms. Grounding is supportive care, not a way to diagnose an episode or a substitute for a neurological treatment plan. See Grounding Techniques for Dissociation.
When a separate dissociative disorder is diagnosed, its psychotherapy plan may require additional work on safety, memory discontinuities, identity-related experiences, or trauma-related distress. The emerging evidence base for interventions in dissociative disorders should not be automatically transferred to FND, just as results from FND rehabilitation trials do not establish the best treatment for dissociative identity disorder. Care planning must state which condition and outcome each intervention is meant to address.
What Functional-Seizure Treatment Trials Really Show
The CODES randomized trial compared dissociative seizure-specific cognitive behavioral therapy plus standardized medical care with standardized medical care alone. The primary outcome—monthly seizure frequency at 12 months—did not show a statistically significant between-group difference, although several secondary measures favored the CBT group. This distinction matters: describing that trial as proof that CBT reliably stops functional seizures would misrepresent its main finding. See Goldstein and colleagues, The Lancet Psychiatry, 2020.
The 2026 AAN guideline assesses available interventions and offers recommendations while acknowledging differences in certainty and patient needs. Treatment decisions are shaped by episode pattern, access to qualified clinicians, concurrent epilepsy, psychiatric comorbidity, functional impact, and patient preferences. The evidence is strongest when interpreted for the population and outcomes actually studied.
Whether treatment reduces depersonalization, improves memory continuity, changes episode frequency, or restores daily functioning involves related but distinguishable outcomes. In a 2025 systematic review of FND treatment outcomes, dissociation-specific findings were mixed across the few studies that measured them. Clinicians should track the patient's important outcomes directly.
Rehabilitation, Daily Functioning, and Prognosis
Treatment success may involve reduced seizure frequency, more consistent walking, improved participation at school or work, improved independence, lower distress, and better confidence managing symptoms. These are different outcomes, and improvement in one does not guarantee immediate recovery in the others. People with persistent symptoms can still benefit from tailored rehabilitation and ongoing health care.
For functional motor symptoms, specialist physiotherapy aims to retrain movement and reduce patterns of unhelpful self-monitoring or avoidance. The Physio4FMD randomized trial provides important controlled evidence, while the 2026 rehabilitation synthesis describes benefits and limitations across studies. The motor-treatment evidence should not simply be presented as a dissociation-specific intervention.
Symptom duration, severity, access to care, concurrent physical illness, social conditions, and comorbid mental health difficulties may affect outcome. A 2025 systematic review and meta-analysis found that longer symptom duration modestly reduced some motor and physical quality-of-life gains without eliminating the possibility of meaningful improvement. The existence of dissociation should prompt appropriate assessment, rather than a prediction of inevitable chronic illness.
Children and Adolescents
Functional symptoms and dissociative experiences in children and adolescents require developmental context. Clinicians ask about the child's physical health, neurological presentation, school participation, sleep, family stressors, relationships, and changes over time. Developmentally ordinary imagination, daydreaming, or shifting emotional states must not automatically be classified as dissociative pathology, while disabling events or new neurological symptoms merit serious assessment.
Family communication is part of care. The goal is to recognize symptoms accurately and support functioning without blaming the child or caregivers. School plans may address attendance, flexibility, graded participation, physical rehabilitation, and emotional needs. The Canadian Paediatric Society's 2024 clinical guidance recommends coordinated, family-centered assessment and care for somatic symptom and related disorders in pediatric populations.
Trauma screening, where clinically indicated, needs to be proportionate, sensitive, and grounded in the child's safety and developmental abilities. Neither an unexplained event nor a functional diagnosis alone establishes abuse or an unreported traumatic history. Medical investigation, safeguarding assessment when independently indicated, and psychological care can proceed together.
Risks of Mislabeling Symptoms
Mislabeling epilepsy as functional seizures can delay needed treatment. Assuming all new neurological symptoms belong to an established FND diagnosis can miss emerging physical disease. Conversely, treating functional symptoms only as evidence of unidentified structural damage can lead to repeated tests or interventions that do not address the diagnosed syndrome. The clinical aim is a specific, revisable formulation grounded in findings and patient needs.
Equating dissociation with deliberate symptom production can damage the therapeutic relationship and undermine care. A person's reported detachment, memory disruption, or altered movement does not establish intent to deceive. Professional evaluation must maintain the distinction between involuntary symptoms and the separate evidence requirements surrounding intentional falsification.
Overinterpreting dissociation as proof of trauma can also cause harm. The literature reports associations and possible mechanisms, with important uncertainty about individual causality. A patient should have the opportunity to discuss relevant life events without being pressured to identify a trauma narrative to justify neurological symptoms.
When Urgent Medical Evaluation Is Important
Sudden new one-sided weakness, facial drooping, difficulty speaking, an abrupt severe headache, a first seizure-like event, severe or prolonged altered consciousness, significant injury, or new persistent confusion requires timely emergency assessment according to local emergency pathways. An existing FND or dissociative diagnosis does not automatically account for a new presentation.
Recurrent events that resemble a person's known functional seizures may follow an individualized safety plan developed with their clinician, but substantial changes in type, duration, injury risk, or recovery should be reassessed. Any medication changes, including antiseizure medications, should be made with the prescribing clinician.
Practical Questions to Discuss With a Clinician
A productive clinical conversation asks which specific findings support the functional neurological diagnosis, which conditions have been evaluated or remain under consideration, and whether any dissociative symptoms require a separate assessment. If episodes occur, it may help to document their onset, subjective experiences, witness observations, recovery, and impact, without experimenting with deliberate symptom provocation.
Treatment planning should identify the patient's priorities: mobility, seizure safety, school or work, sleep, distress, memory continuity, and participation in daily life. The clinician can then explain which interventions target which problems, how progress will be measured, and what changes warrant additional medical evaluation.
A patient can also ask whether neurology, psychiatry, psychology, rehabilitation, and primary care will coordinate a shared plan. Clear communication is especially important when diagnostic systems use different names for similar functional neurological presentations.
Frequently Asked Questions
Is FND a dissociative disorder?
The classification answer depends on the diagnostic system. DSM-5-TR places functional neurological symptom disorder within somatic symptom and related disorders, while ICD-11 places dissociative neurological symptom disorder under dissociative disorders. Neither placement means that every person with FND has a separate identity-related or amnesia-related dissociative diagnosis.
Can dissociation cause FND?
Dissociative symptoms and FND are associated in research, and several mechanisms have been proposed. Existing observational studies do not establish dissociation as a universal cause. Individual causality requires a careful clinical formulation, and some people with FND report little or no dissociation.
Can I have FND and depersonalization/derealization at the same time?
Yes. A person can have functional neurological symptoms and recurrent feelings of detachment from self or surroundings. Whether those feelings constitute a separate disorder depends on their pattern, impairment, medical differential, and diagnostic criteria.
Does FND mean the brain is damaged?
FND is diagnosed through clinical evidence of altered neurological functioning, and routine structural imaging may be normal. Imaging findings do not on their own establish the diagnosis. Structural neurological disease and FND can coexist, so appropriate assessment remains essential.
Are functional seizures the same as dissociative seizures?
The terms commonly refer to overlapping clinical presentations in different classifications and research traditions. They do not imply that the person necessarily has dissociative identity disorder. Functional seizures require an appropriate neurological diagnostic process, including consideration of epilepsy.
Can epilepsy and functional seizures coexist?
Yes. A person may have both diagnoses. This is one reason that a functional-seizure label should never trigger self-directed withdrawal of antiseizure medication or dismissal of new episode types. The AAN guideline addresses diagnostic and treatment considerations.
Does FND always follow trauma?
No. Trauma and stressful experiences are more frequent in some FND study groups, but they are absent from some patients' reported histories. A specific traumatic event is not a required diagnostic criterion, and associations do not prove an individual's cause.
Can a high dissociation score confirm FND?
No. A scale can summarize reported symptoms, but it does not identify positive neurological signs or establish the criteria of a separate disorder. Clinical interviewing and neurological assessment remain necessary.
Is dissociation during a seizure proof that it is non-epileptic?
No. Altered awareness, memory disturbance, and unusual subjective experiences can accompany multiple neurological and psychological conditions. The full event pattern, appropriate investigations, and clinical expertise are necessary for accurate classification.
Can people recover when both FND and dissociation are present?
Improvement is possible, and individualized treatment may address neurological function, episodes, distress, dissociative experiences, and daily participation. Prognosis varies. Present evidence does not support a uniform prediction based on dissociation alone.
Should trauma therapy be the first treatment for everyone with FND?
No universal sequence is supported. Trauma-focused care may be appropriate when a trauma-related disorder is established and the person is ready for that approach. FND-informed rehabilitation, seizure-specific care, psychological treatment, and attention to other medical conditions are selected according to the case.
Related Articles
For the core diagnosis, assessment, and treatment framework, read Functional Neurological Disorder: Symptoms, Diagnosis, and Treatment. For neurologic examination and diagnostic signs, see Functional Neurological Disorder Diagnosis: Positive Signs and Medical Assessment.
The wider dissociation domain is covered in Dissociation: Symptoms, Types, Causes, and When to Seek Help. For closely related experiences, consult Dissociative Episodes: Signs, Duration, and What to Do and Dissociation and Trauma: What Research Shows. These articles address their respective owner intents; the present article addresses the FND–dissociation clinical comparison.
References
American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Publisher DOI.
Aybek, S., & Perez, D. L. (2022). Diagnosis and management of functional neurological disorder. BMJ, 376, o64. DOI: 10.1136/bmj.o64.
Campbell, M. C., et al. (2023). Dissociation and its biological and clinical associations in functional neurological disorder: systematic review and meta-analysis. BJPsych Open. DOI: 10.1192/bjo.2022.597.
Dworetzky, B. A., & Baslet, G. (2025). Functional neurological disorder: Practical management. Neurotherapeutics, 22(4), e00612. DOI: 10.1016/j.neurot.2025.e00612.
Goldstein, L. H., et al. (2020). Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. The Lancet Psychiatry. PubMed PMID 32445688.
Keatley, E. S., et al. (2026). Rehabilitation therapies for functional neurological disorder: A systematic review and meta-analysis of clinical trials. Journal of Neuropsychiatry and Clinical Neurosciences. DOI: 10.1176/appi.neuropsych.20250222.
Ludwig, L., et al. (2018). Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. The Lancet Psychiatry, 5, 307–320. DOI: 10.1016/S2215-0366(18)30051-8.
Mavroudis, I., et al. (2025). Treatment of functional neurological disorder: an umbrella review of systematic reviews and meta-analyses. Journal of Neurology, 272, 710. DOI: 10.1007/s00415-025-13449-7.
Nielsen, G., et al. (2024). Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trial. The Lancet Neurology. PubMed PMID 38768621.
Putica, A., Agathos, J., & Felmingham, K. (2025). How insights from posttraumatic stress disorder can inform treatment of functional neurological disorder. Nature Reviews Psychology, 4, 654–668. Journal article.
Saunders, N. R., et al. (2024). Somatic symptom and related disorders: Guidance on assessment and management for paediatric health care providers. Canadian Paediatric Society. Official clinical guidance.
Thomas, S. T., et al. (2025). Treatment outcomes in functional neurological disorder: a systematic review and meta-analysis exploring the influence of symptom chronicity. BMJ Neurology Open, 7, e001150. Journal article.
Tolchin, B., et al. (2026). Management of Functional Seizures Practice Guideline Executive Summary: Report of the AAN Guidelines Subcommittee. Neurology, 106(1), e214466. DOI: 10.1212/WNL.0000000000214466.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Official WHO publication.
Xue, Q., Pastircakova, Z., Rawlings, G. H., & Reuber, M. (2026). Subjective symptoms of functional/dissociative seizures and their diagnostic value: A systematic review. Epilepsia, 67(5), 2305–2325. DOI: 10.1002/epi.70143.